Medical
Biotechnology
Biopharmaceutical

Amgen

$177.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.35 (0.77%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours

Why Robinhood?

You can buy or sell Amgen and other stocks, options, ETFs, and crypto commission-free!

About AMGN

Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Employees
21,500
Headquarters
Thousand Oaks, California
Founded
1980
Market Cap
108.21B
Price-Earnings Ratio
14.15
Dividend Yield
2.71
Average Volume
2.87M
High Today
$177.77
Low Today
$175.92
Open Price
$176.34
Volume
2.16M
52 Week High
$210.19
52 Week Low
$166.30

Collections

Medical
Biotechnology
Biopharmaceutical
Health
Cancer Prevention
Pharmaceutical
Therapy
Manufacturing

AMGN News

ReutersJul 11

BRIEF-Amgen, Novartis And Banner Alzheimer's Institute Discontinue Clinical Research Program With Bace Inhibitor Cnp520 For Alzheimer's Prevention

16
ReutersJul 11

BRIEF-Novartis, Amgen And Banner Alzheimer's Institute Discontinue Clinical Program With Bace Inhibitor CNP520

119
Barron'sJul 9

Merck, Amgen, and Eli Lilly Get a Drug Pricing Win in Court

476

AMGN Earnings

$2.89
$3.20
$3.52
$3.83
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 30, After Hours

More AMGN News

BloombergJul 3

Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up

221
Yahoo FinanceJun 19

The Zacks Analyst Blog Highlights: Broadcom, Amgen, NVIDIA, Bristol-Myers and Restaurant Brands

412
Yahoo FinanceJun 19

Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data

266
Yahoo FinanceJun 19

Big Drugmakers That May Tread the M&A Path After Pfizer

18
Yahoo FinanceJun 18

See what the IHS Markit Score report has to say about Amgen Inc.

6
Yahoo FinanceJun 14

Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti

6
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.